FDA
-
-
-
-
-
-
-
Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex
-
-
-
-
-
-
-
RedHill initiates enforcement of $10.9 million judgment in Korea
-
-
-
-
-
-
-
RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease
-
-
-
-
-
-
-
CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLORĀ® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE
-
-
-
-
-
-
-
Cumberland Pharmaceuticals gets FDA fast track for DMD heart therapy
-
-
-
-
-
-
-
Cumberland Pharmaceuticals invests $4 million in RedHill's Talicia business
-
-
-
-
-
-
-
Sitryx appoints Adam Mostafa as Chief Financial Officer
-
335,202 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


